Trump Administration Plans to Stick With Tariffs, Trade Representative Says

Jamieson Greer, the president’s top trade negotiator, told the Senate that the United States remained intent on tariffs as it prepared to replace duties the Supreme Court struck down.

By Ana Swanson

Trump Takes Another Swing at Drug Industry in Made-in-USA Push - Bloomberg.com

Trump Takes Another Swing at Drug Industry in Made-in-USA Push  Bloomberg.com

Trump’s generic drug tariffs will drive up pharmaceutical prices

A recipe for cronyism.

By Editorial Board

US trade chief defends tariffs as Democrats say Trump ‘in denial’ over price hikes

Jamieson Greer denies tariffs have pushed up prices during grilling from lawmakers over cost-of-living concerns Donald Trump’s chief trade official denied the president’s sweeping tariffs have increased prices for US families, as lawmakers challenged him over cost-of-living concerns across much of the country. US inflation surged to a three-year high earlier this year. During a heated exchange before US senators on Wednesday, however, US trade representative Jamieson Greer appeared to claim T...

By Shrai Popat in Washington and Lucy Campbell

Trump's trade rep defends new tariffs on Canada

U.S. President Donald Trump's point man on tariffs is justifying the plan to slap new tariffs of 50 per cent on many Canadian products as a means of reducing the U.S. trade deficit.

Trump's generic drug tariffs: What they could mean for medicine prices, manufacturers and supply

Trump's generic drug tariff plan raises questions over prices, U.S. manufacturing and which drugmakers stand to gain or lose as details remain unclear.

Trump to steer billions from universities to AI and individual scientists to counter China

US President Donald Trump’s administration will redirect billions of dollars in federal research funding away from universities to individual scientists and AI-focused projects, arguing the overhaul is needed to help the US compete with China. The plan, outlined in a White House Office of Science and Technology Policy report released on Tuesday, comes as the administration warns that China has reached parity with the US in research and development spending over the past 20 years, “a situation...

By Vincent Chow

Trump’s new conditions on funding the fight against HIV/AIDS require service restrictions

Study reveals that 77% of US partners had to adapt their work to Washington’s latest policies, with conditions surrounding care for the LGBTQ+ community and language censorship

By Ana Puentes

The verdict is in: Canadians hate America thanks to Trump

Four out of five Canadians say they have no confidence in the U.S. under President Donald Trump’s leadership, with existing tensions expected to be exacerbated by latest tariffs

By Joe Sommerlad

Trump’s new tariffs are dubious tactics that put Carney in a tight spot, trade watchers say

Whether the measures are legal may not matter: they put Canada in a difficult position of worsening the trade war or playing Trump's game

By Tracy Moran

Trump's 200% tariff plan may be a bitter pill for US consumers, warns Dr Reddy's

The United States plans significant tariffs on imported generic medicines. These duties will rise to 200% in the coming years. Dr Reddy's Laboratories anticipates higher medicine prices for American consumers. Shifting manufacturing to the US is currently considered impractical by the company. India faces substantial exposure as a major generic medicine exporter to the US.

By TOI BUSINESS DESK

Trump’s Tariffs Enter New Phase, Ending Months of Calm

President Trump is preparing new levies to replace the ones he put in place after the Supreme Court gutted his trade agenda.

64% of Filipinos distrust China – OCTA poll

Most Filipinos continue to have a negative sentiment toward China, with 64 percent saying they distrust the country amid ongoing tensions in the West Philippine Sea, an OCTA Research group survey showed.

By Janvic Mateo

US Set to Impose New Tariffs by Friday With Stopgap to Expire

By moving forward with the latest proposal, Trump would cement his commitment to tariffs, despite voter concerns about the cost of living heading into November’s midterm elections.

By Alicia Diaz, Jennifer A. Dlouhy, Hadriana Lowenkron

UBS Warns Trump's 100% Generic Drug Tariff Puts Indian Pharma "On Notice"; Goldman Flags Reshoring Winners

UBS Warns Trump's 100% Generic Drug Tariff Puts Indian Pharma "On Notice"; Goldman Flags Reshoring Winners President Trump will impose a 100% tariff on imported generic drugs starting in August 2028, rising to 200% a year later, unless manufacturers shift production to the US. "This is done in order to RESHORE Generic Pharmaceutical Production into America, with a penalty to those Companies that decide not to build Plant and Equipment within the stated period of time given to th...

By Tyler Durden